University Of Rochester Cancer Center Community Clinical Oncology Program - Download Free Apps11/29/2016 ![]() New Cancer Center Dedicated The James. The University of Rochester has received $3.7 million in federal. The funding supports the University of Rochester Cancer Center, which has been a part of the National Cancer Institutes Community Clinical Oncology Program. Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Oncology Program Study. University of Rochester Cancer Center VISIT WEBSITE; Am I Eligible? If you are eligible for any of the trials offered by one of our research. A University of Rochester Cancer Center- Community Clinical Oncology Program study of 9. Mayo Clinic. TY - JOURT1 - Cancer patients' expectations of experiencing treatment- related side effects. T2 - Cancer. AU - Hofman,Maarten. AU - Morrow,Gary R. AU - Roscoe,Joseph A. AU - Hickok,Jane T. Prevention of Delayed Nausea: A University of Rochester Cancer Center Community Clinical Oncology Program Study of Patients Receiving Chemotherapy J Clin Oncol Roscoe et al. The following protocol.AU - Mustian,Karen M. AU - Moore,Dennis F. University of Rochester Cancer Center Community Clinical Oncology Program Research Base, University of Rochester Medical Center, Rochester, NY 14642, USA. Community Clinical Oncology Program trial, we investigated the effect of an expectancy manipulation designed to reduce nausea expectancy on chemotherapy-induced nausea in 358 patients scheduled to receive chemotherapy. AU - Wade,James L. AU - Fitch,Tom R. PY - 2. 00. 4/8/1. Y1 - 2. 00. 4/8/1. NCI Community Clinical Oncology Program. University of Rochester Cancer Center. CONTACT DAYTON CLINICAL ONCOLOGY PROGRAM. Thank you for your interest in the Subspecialty Training program in Hematology and Medical Oncology at The University of Arizona College of Medicine and The University of Arizona Cancer Center. Buspirone treatment of dyspnea in outpatients receiving chemotherapy: A University of Rochester Cancer Center Community Clinical Oncology Program (URCC CCOP) study. N2 - < p> BACKGROUND. Adequate management of treatment- related side effects is important for patients and challenging for clinicians. Side effects generated by various treatments have been characterized reasonably well. However, to the authors' knowledge, less is known regarding what patients expect to experience regarding these side effects and how patient characteristics are related to these expectations. Patients with cancer (n = 1. Community Clinical Oncology Program (CCOP) institutions affiliated with the University of Rochester Cancer Center CCOP Research Base were surveyed regarding their expectations of experiencing side effects associated with cancer treatment, with 9. Patients responded to the item, . Patients rated their expectations using a 5- point Likert scale, from 1 (. The median number of symptoms expected (characterized by any value other than one) was nine. The six most expected symptoms were fatigue, nausea, sleep disturbance, weight loss, hair loss, and skin problems. Patients age & gt; 6. Patients with cancer clearly exhibit expectations regarding treatment- related side effects; and age, gender, and education level appear to influence these expectations. Further careful characterization of patient expectations and how expectations relate to experience may lead to earlier and more effective management of side effects. Adequate management of treatment- related side effects is important for patients and challenging for clinicians. Side effects generated by various treatments have been characterized reasonably well. However, to the authors' knowledge, less is known regarding what patients expect to experience regarding these side effects and how patient characteristics are related to these expectations. Patients with cancer (n = 1. Community Clinical Oncology Program (CCOP) institutions affiliated with the University of Rochester Cancer Center CCOP Research Base were surveyed regarding their expectations of experiencing side effects associated with cancer treatment, with 9. Patients responded to the item, . Patients rated their expectations using a 5- point Likert scale, from 1 (. The median number of symptoms expected (characterized by any value other than one) was nine. The six most expected symptoms were fatigue, nausea, sleep disturbance, weight loss, hair loss, and skin problems. Patients age & gt; 6. Patients with cancer clearly exhibit expectations regarding treatment- related side effects; and age, gender, and education level appear to influence these expectations. Further careful characterization of patient expectations and how expectations relate to experience may lead to earlier and more effective management of side effects.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |